“Tianshu Pu1†, Yaru Teng1,2†, Yuezhu Zhang1,2, Meihong Da2, Fei Wang1,2*
1.Medical College, Southeast University, Nanjing, China
2.Department of Dermatology, Zhongda Hospital Southeast University, Nanjing, China.”
Author “Tianshu Pu.” was erroneously assigned to affiliation “Department of Dermatology, ZhongDa Hospital Southeast University, Nanjing, China”. This affiliation has now been removed for author “Tianshu Pu”.
In the published article, there was a mistake in the Funding statement. The Funding statement was displayed as “The author(s) declared that financial support was not received for this work and/or its publication.”. The correct statement is “Zhongda Hospital Southeast University, Jiangsu Province HighLevel Hospital Construction Funds, 2024GSPKY18; Basic Research Program-Natural Science Foundation-Youth Fund Project, Project Number: BK20230838”.
The original version of this article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
cutaneous adverse reactions, dermatology, drug eruptions, ICIS, immune checkpoint inhibitors, immune-related adverse events, severe drug eruptions, Stevens-Johnson Syndrome
Citation
Pu T, Teng Y, Zhang Y, Da M and Wang F (2026) Correction: Immune checkpoint inhibitor-related Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective analysis of 21 cases. Front. Immunol. 17:1804871. doi: 10.3389/fimmu.2026.1804871
Received
05 February 2026
Accepted
06 February 2026
Published
16 February 2026
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
17 - 2026
Updates
Copyright
© 2026 Pu, Teng, Zhang, Da and Wang.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Fei Wang, ffwangfei@163.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.